PubRank
Search
About
Ferry Ossendorp
Author PubWeight™ 56.92
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.
J Clin Invest
2008
3.11
2
Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.
Proc Natl Acad Sci U S A
2005
2.70
3
The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of autoimmune susceptibility.
J Immunol
2011
2.44
4
Proteasome and peptidase function in MHC-class-I-mediated antigen presentation.
Curr Opin Immunol
2004
2.27
5
MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways.
Traffic
2009
1.98
6
Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo.
J Immunol
2002
1.66
7
Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses in the regression of retrovirus-induced sarcomas.
J Immunol
2002
1.46
8
Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes.
Nat Immunol
2010
1.24
9
Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity.
Proc Natl Acad Sci U S A
2009
1.24
10
Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells.
J Biol Chem
2007
1.23
11
Therapeutic cancer vaccines.
J Clin Invest
2015
1.23
12
Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine.
J Immunol
2006
1.19
13
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein.
Blood
2003
1.18
14
Controlled local delivery of CTLA-4 blocking antibody induces CD8+ T-cell-dependent tumor eradication and decreases risk of toxic side effects.
Clin Cancer Res
2013
1.18
15
Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.
Nat Med
2006
1.17
16
Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes.
Immunol Rev
2002
1.16
17
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors.
PLoS One
2011
1.16
18
Ins and outs of dendritic cells.
Int Arch Allergy Immunol
2006
1.16
19
Vaccine-induced effector-memory CD8+ T cell responses predict therapeutic efficacy against tumors.
J Immunol
2012
1.14
20
Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells.
Transplantation
2003
1.03
21
Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes.
Eur J Immunol
2002
1.01
22
Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers.
J Autoimmun
2011
1.00
23
Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer.
Semin Immunol
2013
0.96
24
TLR ligand-peptide conjugate vaccines: toward clinical application.
Adv Immunol
2012
0.95
25
Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus.
J Immunol
2002
0.95
26
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation.
Eur J Immunol
2013
0.93
27
Fcγ receptor IIb strongly regulates Fcγ receptor-facilitated T cell activation by dendritic cells.
J Immunol
2012
0.91
28
2-Azidoalkoxy-7-hydro-8-oxoadenine derivatives as TLR7 agonists inducing dendritic cell maturation.
Bioorg Med Chem Lett
2009
0.89
29
Antitumor efficacy of wild-type p53-specific CD4(+) T-helper cells.
Cancer Res
2002
0.88
30
Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8+ T cells in vivo.
Mol Immunol
2006
0.88
31
Cationic liposomes loaded with a synthetic long peptide and poly(I:C): a defined adjuvanted vaccine for induction of antigen-specific T cell cytotoxicity.
AAPS J
2014
0.85
32
Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.
Immunology
2006
0.85
33
TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors.
J Clin Invest
2016
0.85
34
Gamma irradiation or CD4+-T-cell depletion causes reactivation of latent Salmonella enterica serovar Typhimurium infection in C3H/HeN mice.
Infect Immun
2005
0.84
35
Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines.
Vaccine
2011
0.84
36
N-tetradecylcarbamyl lipopeptides as novel agonists for Toll-like receptor 2.
J Med Chem
2014
0.84
37
Circulating specific antibodies enhance systemic cross-priming by delivery of complexed antigen to dendritic cells in vivo.
Eur J Immunol
2012
0.84
38
Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells.
Mol Immunol
2008
0.83
39
Steric hindrance and fast dissociation explain the lack of immunogenicity of the minor histocompatibility HA-1Arg Null allele.
J Immunol
2009
0.83
40
CD8 T-cell recognition of human 5T4 oncofetal antigen.
Int J Cancer
2006
0.83
41
A novel role of complement factor C1q in augmenting the presentation of antigen captured in immune complexes to CD8+ T lymphocytes.
J Immunol
2007
0.83
42
Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles.
Cancer Immunol Immunother
2013
0.82
43
New role of signal peptide peptidase to liberate C-terminal peptides for MHC class I presentation.
J Immunol
2013
0.82
44
Receptor-mediated targeting of cathepsins in professional antigen presenting cells.
Angew Chem Int Ed Engl
2009
0.80
45
Effective CD8(+) T cell priming and tumor protection by enterotoxin B subunit-conjugated peptides targeted to dendritic cells.
Vaccine
2009
0.80
46
Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitope.
J Immunother
2002
0.79
47
Synthesis of 2-alkoxy-8-hydroxyadenylpeptides: towards synthetic epitope-based vaccines.
Bioorg Med Chem Lett
2006
0.79
48
The efficiency of human cytomegalovirus pp65(495-503) CD8+ T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidases.
J Immunol
2012
0.78
49
New chelation strategy allows for quick and clean 99mTc-labeling of synthetic peptides.
Nucl Med Biol
2004
0.77
50
DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg.
Eur J Immunol
2009
0.77
51
Intraendosomal flow cytometry: a novel approach to analyze the protein composition of antigen-loaded endosomes.
Eur J Immunol
2012
0.77
52
Synthesis of modified and hybrid protein derived biopolymers.
Adv Exp Med Biol
2009
0.75
53
The Optimization of Bioorthogonal Epitope Ligation within MHC-I Complexes.
ACS Chem Biol
2016
0.75
54
Evaluation of the high-pressure extrusion technique as a method for sizing plasmid DNA-containing cationic liposomes.
J Liposome Res
2011
0.75
55
Particulate Systems Based on Poly(Lactic-co-Glycolic)Acid (pLGA) for Immunotherapy of Cancer.
Curr Pharm Des
2015
0.75